Biopsy

Template Mapping Biopsies: An Overview of Technique and Results Deepika Reddy et al., November 2021

Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis Edward J. Bass et al., September 2021

Switching from sedation to local anaesthetic transperineal prostate biopsies: A cost-benefit analysis Uma Walters et al., September 2021

Impact of non-targeted prostate sampling histology on the probability of receiving invasive local treatment in an mpMRI-targeted pathway – analysis of 1,719 men Martin J. Connor et al., June 2021

MRI and Targeted Biopsies Compared to Transperineal Mapping Biopsies Prior to Focal Ablation in Recurrent Prostate Cancer after Radiotherapy Taimur T. Shah et al., January 2021

Review article: MRI-targeted biopsies for prostate cancer diagnosis and management Mohamed E. Noureldin et al., January 2021

A Comparison of Prostate Cancer Detection Between Visual-Estimation (Cognitive Registration) and Image-Fusion (Software Registration) Targeted Transperineal Prostate Biopsy Christopher C. Khoo et al., November 2020

Man vs machine: Comparative effectiveness of cognitive targeted and image-fusion targeted transperineal prostate biopsy Christopher C. Khoo et al., July 2020

Transperineal biopsy of the prostate with image fusion: A suggested technique and cancer detection rates Arnas Rakauskas et al., July 2020

A Multicentre Study of the Clinical Utility of Non-targeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-biopsy mpMRI Martin J. Connor et al., June 2020

Direct and marginal cost analysis of not aiming for the target in a MRI-targeted prostate biopsy pathway Martin J. Connor et al., April 2020

A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach Saiful Miah et al. February 2020

Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy Martin J. Connor et al., August 2019

A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk Saiful Miah et al., March 2019

Focal Therapy

Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control Marieke J. van Son et al., December 2021

Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study Taimur T. Shah et al., June 2021

Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer? Arnas Rakauskas et al., May 2021

Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning David Eldred-Evans et al., August 2020

Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: A propensity matched study Deepika Reddy et al., July 2020

Prostate imaging and focal therapy Martin J. Connor et al., June 2020

Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure Deepika Reddy et al., May 2020

An exploratory study of dose escalation versus standard focal High Intensity Focused Ultrasound for treating non-metastatic prostate cancer Hashim U. Ahmed et al., April 2020

Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; Results from the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry Catherine Lovegrove et al., January 2020

PSA Criteria to Diagnose Failure of Cancer Control following Focal Therapy for Non-metastatic Prostate Cancer Using High Intensity Focused Ultrasound Phillipp M. Huber et al., January 2020

Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer Taimur T. Shah et al., October 2019

A systematic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer Christopher C. Khoo et al., August 2019

Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry Taimur T. Shah et al., July 2019

A comparison of cancer control outcomes at 5 years of focal therapy (using HIFU & Cryotherapy) to radical prostatectomy for clinically significant non-metastatic prostate cancer: propensity score-matched analysis Taimur T. Shah et al., April 2019

Prostatectomy

Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? Nicholas Raison et al., November 2021

Patient and disease specific risk factors and nerve sparing have a significant impact on long term sexual functional following minimally invasive radical prostatectomy Nicholas Raison et al., September 2021

Patient-specific risk factors and post-operative complications have a significant impact on long term functional outcomes following radical prostatectomy Nicholas Raison et al., September 2021

Active Surveillance

Rethinking active surveillance for the multiparametric magnetic resonance imaging era David Eldred-Evans et al., March 2019

Treatment

Prostate cancer in transgender women: what does a urologist need to know? Mariana Bertoncelli-Tanaka et al., June 2021

Autonomous surgery in the era of robotic urology: friend or foe of the future surgeon? Martin J. Connor et al., September 2020

Made of hard stuff: Why was significant bone disease seemingly less common in the eunuchs of China and Turkey than in patients today undergoing androgen deprivation therapy? William Maynard et al., April 2020

The effects of testosterone replacement therapy on the prostate: a clinical perspective Saiful Miah et al., February 2019

Advanced Disease

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer Martin J. Connor et al., November 2021

MRI findings in de novo synchronous metastatic prostate cancer and implications for cytoreductive surgery Martin J. Connor et al., September 2021

Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): Protocol for a multicentre, phase II randomised controlled trial Martin J. Connor et al., February 2021

Radical Treatment Without Cure: Decision-making in Oligometastatic Prostate Cancer Martin J. Connor et al., February 2021

Clinical Translation of Positive Metastases Identified on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Management of De Novo Synchronous Oligometastatic Prostate Cancer Martin J. Connor et al., December 2020

Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials Martin J. Connor et al., September 2020

Survival in Oligometastatic Prostate Cancer—A New Dawn or the Will Rogers Phenomenon? Martin J. Connor et al., December 2019

Cytoreductive treatment strategies for de novo metastatic prostate cancer Martin J. Connor et al., November 2019

Rezum

363 Patient-Reported Outcomes Measures From 153 Men Treated with Water Vapour Thermal Therapy (Rezūm) For Symptomatic Benign Prostate Hyperplasia Amar Rai et al. October 2021

Preservation of sexual function following Rezum therapy for LUTS/BPH too good to be true? Real world outcomes from 181 cases Martin J. Connor et al., September 2021

RAPID Pathway

Re-referral rates in the medium term in patients with a non-suspicious Mp-MRI within the RAPID Pathway Mariana Bertoncelli-Tanaka et al., September 2021

Impact of non-targeted prostate sampling histology on the probability of receiving invasive local treatment in an Mp-MRI targeted pathway - Analysis of 1,719 men Martin J. Connor et al., September 2021

Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases? Martin J. Connor et al., July 2020

The RAPID risk model: A novel risk score to predict significant prostate cancer in men with an mpMRI lesion David Eldred-Evans et al., July 2020

The RAPID risk score: Development of a novel risk score to predict significant prostate cancer in men with an MpMRI lesion David Eldred-Evans et al., April 2020

The RAPID access prostate imaging and diagnosis (RAPID) pathway - A multicentre update of 1719 patients undergoing multi-parametric MRI as a triage test Edward J. Bass et al., April 2020

IP1-PROSTAGRAM

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography—The IP1-PROSTAGRAM Study—Reply David Eldred-Evans et al., August 2021

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study David Eldred-Evans et al., February 2021

Rethinking prostate cancer screening: could MRI be an alternative screening test? David Eldred-Evans et al., July 2020

Population-based prostate cancer screening using a prospective, blinded, paired screen-positive comparison of PSA and fast MRI: The IP1-PROSTAGRAM study David Eldred-Evans et al., May 2020

IP2-ATLANTA

Initial experience of the adjuvant treatments to the local tumor for metastatic prostate cancer: Assessment of novel treatment algorithms, a multicenter, phase II randomized controlled trial (IP2-ATLANTA) Martin J. Connor et al., May 2020

IP2 – ATLANTA is launched! Martin J. Connor et al., April 2019

IP3-PROSPECT

PROState pathway embedded comparative trial: The IP3-PROSPECT study Edward J. Bass et al., June 2021

IP4-CHRONOS

Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study Emily Day et al., August 2021

Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial Deepika Reddy et al., April 2020

IP5-MATTER

A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer Martin J. Connor et al., December 2021

Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study Martin J. Connor et al., December 2021

Metastatic prostate cancer patients’ Attitudes towards Treatment of the local Tumour and metastasis Evaluative Research (IP5-MATTER): A multicentre, discrete choice experiment trial-in-progress Martin J. Connor et al., June 2021